menu search

ADAG / Is Adagene (ADAG) Stock Outpacing Its Medical Peers This Year?

Is Adagene (ADAG) Stock Outpacing Its Medical Peers This Year?
Here is how Adagene Inc. Sponsored ADR (ADAG) and The Cooper Companies (COO) have performed compared to their sector so far this year. Read More
Posted: May 25 2023, 10:46
Author Name: Zacks Investment Research
Views: 110555

ADAG News  

Is Adagene (ADAG) Outperforming Other Medical Stocks This Year?

By Zacks Investment Research
September 27, 2023

Is Adagene (ADAG) Outperforming Other Medical Stocks This Year?

Here is how Adagene Inc. Sponsored ADR (ADAG) and AN2 Therapeutics, Inc. (ANTX) have performed compared to their sector so far this year. more_horizontal

Is Adagene (ADAG) Stock Outpacing Its Medical Peers This Year?

By Zacks Investment Research
May 25, 2023

Is Adagene (ADAG) Stock Outpacing Its Medical Peers This Year?

Here is how Adagene Inc. Sponsored ADR (ADAG) and The Cooper Companies (COO) have performed compared to their sector so far this year. more_horizontal

Adagene Shares Pop After FDA Clears Phase 1b/2 Trial For ADG126/Keytruda Combo Therapy In Solid Tumors

By Benzinga
March 16, 2022

Adagene Shares Pop After FDA Clears Phase 1b/2 Trial For ADG126/Keytruda Combo Therapy In Solid Tumors

The FDA has cleared Adagene Inc's (NASDAQ: ADAG) Phase 1b/2 clinical trial of its anti-CTLA-4 monoclonal antibody (mAb), ADG126, in combination wit more_horizontal


Search within

Pages Search Results: